All Industries

Saint Paul Public Housing Agency and Comcast Announce Technology Partnership

Comcast Twin Cities

The Saint Paul Public Housing Agency (PHA) and Comcast today announced they have partnered to provide a WiFi connection to Xfinity's advanced network in all 16 of PHA’s buildings in Saint Paul. The partnership is Comcast’s first collaboration with a Minnesota-based housing agency to provide pre-installed, already on connectivity to the Xfinity network for their residents. More than 2,500 units will be equipped with Xfinity’s fast and reliable network and wall-to-wall WiFi coverage. With Xfinity’s network readily available, residents will not need to schedule a technician to set up services, wait for their modem to arrive or go to an Xfinity Store to collect their equipment. To activate service, residents will only need to call or use the Xfinity App. “Internet access provides connectivity to 21st century infrastructure, equipping our residents with the tools vital to enhancing opportunities for education, employment, and quality of life," said Saint Paul Mayor Melvin Carter. "The collaboration between Saint Paul Public Housing Agency and Comcast empowers our neighbors to realize a brighter future.” Current residents and new residents moving into WiFi ready units can connect to the Internet within five minutes of collecting their keys—making it that much easier to get all their devices up and running. “Access to WiFi isn’t just about connecting devices; for us it’s about connecting PHA residents to opportunity,” said PHA Board Chair Missy Staples Thompson. “Making PHA-owned high-rises WiFi-ready can help residents cross the digital divide and open doors to education, employment, and empowerment. We appreciate this partnership with Comcast that will benefit residents and their communities.” The Xfinity network will be installed in phases. Completion of the first two buildings just occurred, and 14 additional buildings will have WiFi ready units residents can connect to by the end of 2024. About Comcast Corporation Comcast Corporation (Nasdaq: CMCSA) is a global media and technology company. From the connectivity and platforms we provide, to the content and experiences we create, our businesses reach hundreds of millions of customers, viewers, and guests worldwide. We deliver world-class broadband, wireless, and video through Xfinity, Comcast Business, and Sky; produce, distribute, and stream leading entertainment, sports, and news through brands including NBC, Telemundo, Universal, Peacock, and Sky; and bring incredible theme parks and attractions to life through Universal Destinations & Experiences. Visit www.comcastcorporation.com for more information. About the Saint Paul Public Housing Agency (PHA) The PHA administers federal rent subsidies that provide safe, affordable housing to more than 22,000 Saint Paul residents. Almost half of those residents live in the 4,273 affordable homes and apartments that the PHA owns and manages. The PHA also administers the federal rent subsidy program called “Housing Choice Vouchers”, previously known as Section 8. The rental vouchers help 5,243 households pay affordable rents in privately-owned apartments and rental homes. Contact Details Jill Hornbacher +1 651-425-1695 Jill_Hornbacher@comcast.com Company Website https://midwest.comcast.com

June 11, 2024 01:00 PM Central Daylight Time

Image

News Release

Rising Bond Yield A Threat For Bitcoin, Investors Pouring Millions To GFOX

RoundHouse Media

The rising bond yields in the USA could impact investments in alternative assets like Bitcoin. Interest rates in 2024 range just over 5%, an increase from the average for most of the last decade. Investors are exploring alternative assets like $GFOX that offer more upside. Rising bond yields in the USA could dampen the appetite for alternative investments like Bitcoin. The Federal Reserve has kept the interest rates at a fairly high level since the Covid-19 Pandemic, which means better returns for bond investors. Bitcoin is still on a historic tear after a solid start to the year. A combination of the halving event and positive regulatory developments have added wind to the sails of the pioneer crypto. Investors keen on untapped potential are looking into exciting new projects like Galaxy Fox ($GFOX) for more upside. This project has strong momentum after listing on Uniswap in April and looks to be the next $1 crypto. Rising Bond Yields Could Affect Bitcoin US treasury bond yields have hit a four-month high, increasing the attractiveness of this investment. Bonds are some of the most stable investments in the financial markets and the higher return consolidates this advantage. The high level of yield could be to the detriment of other equities and alternative assets. Stock markets continue to operate at record highs making notable stocks expensive for traders. The possibility of getting excellent returns for bonds makes them a more attractive proposition. Bitcoin could also feel some of the aftershocks. Competing against high yield from the most stable investment in the financial sector is a tall order. That said, Bitcoin prices are a unique phenomenon and may not have the predicted symmetry with traditional financial markets. $GFOX Offers A Rising Alternative To BTC Bitcoin continues to hold steady but appears headed for a period of consolidation. Investors looking for assets with more upside potential are looking at growing altcoin projects for alternatives. One such proposition is Galaxy Fox ($GFOX). This utility meme coin continues to draw plaudits after launching its play-to-earn game (P2E) game in May. $GFOX is an ERC-20 and, therefore, broadly compatible with Ethereum wallets. Galaxy Fox’s gaming ecosystem involves players raising digital fox characters to engage in epic battles within the game. The players earn various rewards within the game in crypto tokens, making gameplay lucrative. This game also has NFT collectibles for players to improve their portfolios. The NFTs are unique and allow the player to track ownership effectively, which is useful for gaming items. Having NFTs ensures that players can leverage their gameplay for value within the ecosystem. The possibility of staking $GFOX adds more opportunities for users. This ecosystem looks to elevate the meme coin experience and create sustainability. Newer memecoins that purely rely on meme notoriety have not challenged Dogecoin significantly. Therefore, investors are looking at this project keenly as one of the credible alternatives in a transitioning market. For Info about $GFOX, visit Galaxyfox.io Conclusion Competing with treasury bonds is a tall order for any other asset class. After all, an investment with the backing of the government of the world’s largest economy having high yield is very endearing. Nonetheless, the crypto market has proven its resilience in varying market conditions. Bitcoin will likely consolidate, with emerging assets that have strong upside likely to gain some tailwinds. $GFOX fits the bill as a strong new asset with incredible potential. Its strong launch is a testament to the belief in this project and should continue as it continues to gain more dimension. Visit the Galaxy Fox website today to learn more about the project. Learn more about $GFOX here: Galaxyfox.io | Join the Community Contact Details Roundhouse Media media@galaxyfox.io

June 11, 2024 01:00 PM Eastern Daylight Time

Voyageur Pharmaceuticals and Rain Cage Carbon Partner to Develop Advanced Radiology Contrast Agents

Voyageur Pharmaceuticals Ltd

Voyageur Pharmaceuticals CEO Brent Willis joined Steve Darling from Proactive to announce that the company and Rain Cage Carbon are advancing their collaboration following the first commercial creation of a V@C60 endohedral fullerene or Vanadium atom inside a C60 molecule. Rain Cage is now embarking on the next phase of radiology drug development using their cutting-edge technology. Willis told Proactive that Rain Cage will begin working to create on a commercial scale, the encapsulation of gadolinium, bismuth, and iodine within endohedral fullerenes. This pioneering work, set to begin later this month, aims to develop a process to create Gd@C60, Bi@C60, and I@C60 endohedral fullerenes, targeting the development of highly advanced radiology contrast agents for Magnetic Resonance Imaging (MRI) and CT scans. These novel compounds, known for their rarity and complex synthesis, hold the promise of transforming medical imaging by significantly enhancing the precision and clarity of radiological scans. Endohedral fullerenes are a class of fullerenes that enclose an additional atom, ion, or cluster within their inner sphere, exhibiting superior physical and electronic characteristics compared to regular fullerenes. In the context of radiology drugs, endohedral metallofullerenes offer distinct advantages through exceptional stability and bioavailability, an amplified signal that leads to better image clarity and resolution, targeted delivery, and reduced toxicity. These properties have garnered interest in applications such as MRI contrast agents Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

June 11, 2024 12:50 PM Eastern Daylight Time

Video

Aclara Resources Announces New Environmental Impact Assessment for Penco Module Rare Earths Project

Aclara Resources Inc

Aclara Resources Chief Financial Officer Francois Motte joined Steve Darling from Proactive to share exciting news: the company has announced the filing of a new Environmental Impact Assessment for the Penco Module rare earths project with the Environmental Service Assessment (SEA) in Chile. The EIA incorporates an improved technical design of the project, which the company believes addresses all concerns related to environmental and social requirements from public services and local communities. Additionally, the EIA has been optimized following a review conducted by CAP S.A. Motte told Proactive that the company has held meetings with over 1,000 residents, leaders, and opinion leaders of Penco, receiving 303 recommendations and comments. The company states that the changes in the EIA present a smaller but more robust project that maintains the positive aspects of the previous EIA, such as a fully recycled water source, revegetation with native species, and the generation of over 2,000 direct and indirect jobs. Environmental stewardship remains at the core of Aclara, and the company has taken an active approach to protecting native species through a program aimed at distributing a significant number of "naranjillos" and other vulnerable native species to social and regional organizations in the Biobio region and other areas in Chile for conservation. The next steps include submitting the EIA, expecting a positive admissibility within five days, followed by a 40-day observation period by authorities. The evaluation process will involve both technical assessment and public consultation, where Aclara will present the project's improvements. Contact Details Proactive Canada +1 604-688-8158 na-editorial@proactiveinvestors.com

June 11, 2024 12:42 PM Eastern Daylight Time

Video

Pantheon Resources Releases Independent Expert Report Confirming Significant Resource Estimates

Pantheon Resources PLC

Pantheon Resources Executive Chairman David Hobbs joined Steve Darling from Proactive to announce the company has released the results of the recent Independent Expert Report by Cawley Gillespie & Associates. This report completes the independent estimates for the Company's aggregate resources from the Kodiak field, Ahpun western topsets, and Alkaid horizon, resulting in totals exceeding 1.5 billion barrels of ANS Crude and 6.5 trillion cubic feet of associated gas. The company states that the Ahpun topsets on the west side of the Dalton Highway can be economically developed, even after excluding the potential market offtake for natural gas. The best estimate of 282 mmbbl of contingent recoverable resources of ANS crude and 803 billion cubic feet of natural gas underscores Pantheon's ability to support the in-State phase of the Alaska LNG project, initially with Ahpun volumes and with its Kodiak field resources. Hobbs told Proactive that the report evaluated the economics of the best estimate or 2C case. Based on an ANS Crude price of $80 per barrel delivered to the US West Coast, CGA estimates the net present value of the total contingent resources in the western topsets in the Ahpun field at $1.74 billion. This report extends the independent assessments of all the Company's contingent resources discovered, appraised, and for which development approvals are being prepared. As previously announced, the Company is targeting a Final Investment Decision at the earliest possible date subject to regulatory consents, but in any case, to allow first production no later than 2028. Contact Details Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

June 11, 2024 12:17 PM Eastern Daylight Time

Video

Pyxis Tankers chairman and CEO on market outlook and growth strategies

Pyxis Tankers Inc

Pyxis Tankers Inc (NASDAQ:PXS) chairman and CEO Valentios (Eddie) Valentis, talked with Proactive about the recent Posidonia shipping event and its impact on the shipping industry. Valentis shared his insights on the optimistic outlook for shipping sectors despite global headwinds. He highlighted that industry players are leveraging substantial cash balances to pay down debt, renew fleets, and make significant shareholder distributions. Valentis noted the strong chartering environment for product tankers, influenced by tighter inventories and changing trade patterns due to geopolitical conflicts. Discussing market conditions, Valentis provided an update on product tankers and dry bulk sectors. He mentioned the positive near-term outlook supported by refinery additions and OPEC+ supply cuts. Additionally, Valentis shared Pyxis Tankers' recent performance, including Q1 2024 financial results, fleet expansion, and new acquisitions. He also outlined the company's shareholder value enhancement initiatives, such as share buyback programs and reducing convertible preferred shares. Valentis said the favourable prospects for both sectors and its existing capital resources allow Pyxis to actively pursue value-enhancing investment opportunities. Contact Details Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

June 11, 2024 11:40 AM Eastern Daylight Time

Video

Busting the Myths Around Weight Loss Medication

YourUpdateTV

Obesity is one of the most common chronic health issues in the U.S. today, and can lead to or exacerbate many other significant physical and mental health challenges, including type 2 diabetes, heart disease and depression. But GLP-1 injections are an impactful new tool that can help people on their weight loss journey. Recently, Dr. Craig Primack, the Senior Vice President of Weight Loss at Hims and Hers, participated in a nationwide satellite media tour to discuss the impact of obesity, common myths surrounding weight loss medications, and personalized options that can help. A video accompanying this announcement is available at: https://youtu.be/NGNz92bi7nY Research shows that even just 5-10% of body weight loss can improve blood pressure, blood sugar, cholesterol, joint pain, sleep apnea, and other weight-related conditions. Weight loss drugs like GLP-1 medication are not only an exciting tool in the weight loss tool belt but can help to address the challenges associated with obesity. GLP-1 injections can support healthy weight loss along with a reduced calorie diet and increased exercise. Some common myths regarding weight loss medications, include: ● Many people assume that weight loss medications are magic. Weight loss drugs can be excellent tools for decreasing hunger and therefore reducing overall calorie intake, but their effects are not instant and should be combined with a healthy lifestyle approach, including a balanced diet and regular exercise. ● People also assume that the injections are painful. The injection is a very small needle that goes just under the skin. It feels like a small pinch, and is quite painless. For the most part, people do great with self-administering GLP-1 injections. ● Lastly, many people think that weight loss drugs come with dangerous side effects. Like all medications, there is a risk of side effects, but there are really only three common side effects associated with GLP-1’s, and they are generally mild: nausea, heartburn, and constipation. The benefits of these drugs far outweigh the risks for many, especially when compared to the health risks associated with being overweight. Hims & Hers’ personalized approach means custom treatment for individual needs to minimize these side effects. Known for its holistic, personalized approach to health and wellness, Hims & Hers is now offering access to GLP-1 injections designed for affordability and effectiveness. These are the four things you should know. ● Hims & Hers’ weight loss program is tailored to an individual’s needs and includes customized medication kits or GLP-1 medication, as determined appropriate by the healthcare provider. ● The science-backed and doctor-developed program is available 100% online for as little as $199 a month. ● Through the app, a licensed healthcare provider will work with you to decide the recommended treatment, plus provide realistic nutritional tips with easy to follow snack and meal ideas. ● Hims & Hers takes the safety of each customer very seriously. The pharmacies the brand works with provide sterile, single-use syringes with each GLP-1 shipment, and products are made with active ingredients from FDA regulated suppliers. And, injection medications are shipped in cold packs for temperature control in transit in the summer weather. For more information, visit hims.com/glp1 or forhers.com/glp1 About Dr. Craig Primack MD, FACP, FAAP, MFOMA Dr. Craig Primack is the Senior Vice President of Weight Loss at Hims & Hers. He completed his undergraduate studies at the University of Illinois and subsequently attended medical school at Loyola University — The Stritch School of Medicine. He completed a combined residency in Internal Medicine and in Pediatrics at Banner University- Phoenix, and Phoenix Children's Hospital. He received post-residency training in Obesity Medicine and is one of about 7,000 physicians in the U.S. certified by the American Board of Obesity Medicine. In 2006, Dr. Primack co-founded Scottdale Weight Loss Center in Scottsdale, Arizona, where he began practicing full-time obesity medicine. Scottsdale Weight Loss Center has grown since then to six obesity medicine clinicians in four locations around the greater Phoenix Metropolitan area.From 2019–2021, he served as president of the Obesity Medicine Association (OMA), a society of over 5,400 clinicians dedicated to clinical obesity medicine. He proudly served on the OMA board from 2010-2024, most recently as ex-officio trustee. Dr. Primack routinely does media interviews regarding weight loss and regularly speaks around the country educating medical professionals about weight loss and obesity care. He is co-author of the book, “Chasing Diets.” Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

June 11, 2024 11:37 AM Eastern Daylight Time

Video

SHARE Series Live at NYSE

SHARE Series

SHARE Series is hosting an event at the New York Stock Exchange on Friday, June 14th. The event will feature presentations from high growth small-cap companies Vera Bradley (NASDAQ: VRA), A.K.A. Brands (NYSE: AKA), Brilliant Earth (NASDAQ: BRLT), and Blade (NASDAQ: BLDE), as well as private companies 6666 and Equitea. All presentations will be webcast live on the SHARE platform. Interested viewers can register and attend for free at the Share Series website. Archived replays will be available on the SHARE Series website following the events. About SHARE Series SHARE offers management teams a unique opportunity to tell their investment story to their growing retail shareholder base through their platform and expanded distribution network. SHARE is the only event that reaches 100% of the investment community, with a focus on investors who manage <$100M and do not file 13f ownership reports. This group includes family wealth offices, small hedge funds, regional investment advisors, and high net worth individuals, in addition to individual investors. Contact Details Dan Aldridge +1 404-740-0638 dan@shareconferenceseries.com Company Website https://share-series.open-exchange.net

June 11, 2024 10:43 AM Eastern Daylight Time

Tonix Pharmaceuticals Nears Market Entry with Tonmya for Fibromyalgia Management

Tonix Pharmaceuticals

Tonix Pharmaceuticals CEO Dr. Seth Lederman joined Steve Darling from Proactive to announce the completion of the initial phase of an assessment conducted by EVERSANA® Life Science Services, LLC on the U.S. market opportunity for Tonmya. Tonmya represents a potential groundbreaking first-line therapy for fibromyalgia management, positioning itself as a non-opioid, centrally-acting alternative in a market dominated by opioids. Lederman highlighted the concerning dominance of opioids in the fibromyalgia prescription market, despite well-documented risks of dependency. Tonmya aims to address this gap by offering a safer, non-addictive option for fibromyalgia patients. EVERSANA's primary market research indicates promising interest from physicians, with a median interest rating of 4.0 on a 5-point scale and an intended use of Tonmya in 40% of fibromyalgia patients upon approval. The analysis also noted that approximately 50% of fibromyalgia patients in the U.S. are on Medicare. The Inflation Reduction Act, effective in 2025, will cap out-of-pocket prescription drug costs for Medicare patients, which could improve access to Tonmya if approved. With the submission of the New Drug Application (NDA) for Tonmya slated for the second half of the year, Tonix Pharmaceuticals anticipates an FDA decision on approval by 2025. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

June 11, 2024 10:26 AM Eastern Daylight Time

Video

1 2 3 4 5 ... 3607